Boston Scientific Corporation
300 Boston Scientific Way
Tel: (800) 876-9960
1495 articles with Boston Scientific Corporation
Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area). Here’s a look at 13 Massachusetts life science companies that are showing both gains and losses—...
Acquisition to Bolster Company's Venous Therapies Portfolio within Peripheral Interventions Division
Updated: Boston Scientific Continues M&A Spree with $160 Million Deal for Veniti; Lays Off 85 in ...
8/8/2018Two days after Boston Scientific laid off 85 employees at a Burlington, Mass. manufacturing site, the company forked over up to $160 million to acquire California stent maker Veniti, Inc. The deal marks the third acquisition for Boston Scientific in two months.
Boston Scientific Closes Acquisition of Claret Medical, Inc., Announces Positive Reimbursement Decision
CMS Grants NTAP Designation for The Sentinel® Cerebral Protection System
Boston Scientific Corporation is scheduled to participate in the 38th Annual Canaccord Genuity Growth Conference on Wednesday, August 8, 2018 in Boston.
Summary Judgment Ruling Affirms Method Claims Covering 1.5kHz to 100kHz Frequency Range
Boston Scientific Corporation generated sales of $2.490 billion during the second quarter ended June 30, 2018.
Boston Scientific Corporation Recommends Stockholders Reject 'Mini-Tender' Offer by TRC Capital Corporation
Boston Scientific Corporation has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation (TRC) to purchase up to three million shares of Boston Scientific's common stock
Addition of FDA-cleared Sentinel® Cerebral Embolic Protection System to Expand Company's Structural Heart Offerings
Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform
Boston Scientific Corporation will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2018 on Wednesday, July 25, 2018 at 8:00 a.m. EDT.
AirXpanders, Inc., (ASX: AXP), announced that it has appointed a new President and CEO, Mr. Frank Grillo.
The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.
Tenax Therapeutics, Inc. today announced the Company has selected board member Anthony A. DiTonno to be its next Chief Executive Officer, effective June 1, 2018.
Boston Scientific announced key data that will be presented at Digestive Disease Week (DDW).
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 34th Annual Strategic Decisions Conference on May 31, 2018 in New York.
Boston Scientific Corporation announced the close of its acquisition of NxThera.
The difference between the salaries paid to top executives and the median income earned by rank and file employees has been a sore subject for many years and has served as a wedge political issue in recent elections.
Boston Scientific Corporation generated sales of $2.379 billion during the first quarter ended March 31, 2018.
Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized, sham-controlled, multi-center study of deep brain stimulation (DBS) for advanced, levodopa-responsive Parkinson's disease (PD) in the United States.